Core Information
(As of June 25, 2024)
| Company name |
ASKA Pharmaceutical Holdings Co., Ltd. |
| Address |
5-1, Shibaura 2-Chome, Minato-ku, Tokyo 108-8532, Japan
Tel: +81-3-5484-8845
|
| Established |
April 1, 2021 |
| Capital |
¥1,197.9 million (as of March 31, 2020) |
| Business segments |
Business management of group companies and related businesses |
| Representative |
Takashi Yamaguchi
President, Representative Director |
| Executives |
Please see the list of Executives. |
| Number of Employees (Consolidated) |
762 (127)* |
| URL |
https://www.aska-pharma-hd.co.jp/english/ |
| Corporate Profile |
Download |
| Audit Firm |
Seiyo Audit Corporation |
| Book Runner |
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. |
| Main Bank |
MUFG Bank / Sumitomo Mitsui Banking Corporation / Mitsubishi UFJ Trust and Banking Corporation |
*Number of employees is the number of full-time employees who actually work as of March 31, 2024. Figures in parentheses represent the average number of temporary employees during the year and are not included in the number of full-time employees. The number of employees includes those who concurrently work at our Group companies.